REA, Silvio
 Distribuzione geografica
Continente #
NA - Nord America 4.571
EU - Europa 2.695
AS - Asia 1.480
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 6
AF - Africa 3
Totale 8.773
Nazione #
US - Stati Uniti d'America 4.555
IE - Irlanda 883
CN - Cina 684
TR - Turchia 619
SE - Svezia 398
DE - Germania 330
UA - Ucraina 294
GB - Regno Unito 290
IT - Italia 197
FI - Finlandia 158
SG - Singapore 124
FR - Francia 85
IN - India 31
BE - Belgio 17
CA - Canada 15
AU - Australia 10
CH - Svizzera 8
IL - Israele 8
EU - Europa 7
PL - Polonia 7
RU - Federazione Russa 7
BR - Brasile 5
NL - Olanda 4
VN - Vietnam 4
CZ - Repubblica Ceca 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
KR - Corea 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
HN - Honduras 1
IM - Isola di Man 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 8.773
Città #
Jacksonville 1.175
Chandler 980
Dublin 882
Boardman 397
Izmir 296
San Mateo 247
Nanjing 214
Wilmington 170
Lawrence 147
Princeton 147
Milan 88
Ann Arbor 84
New York 82
Singapore 78
Nanchang 72
Shenyang 57
Des Moines 54
Woodbridge 51
Seattle 49
Hebei 47
Mountain View 40
Verona 40
Jiaxing 39
Beijing 33
Shanghai 30
Ashburn 28
Kunming 24
Tianjin 21
Changsha 19
Jinan 19
Brussels 17
Ningbo 17
Pune 17
Zhengzhou 17
San Francisco 16
Dearborn 14
Norwalk 14
Helsinki 13
Düsseldorf 12
Falls Church 12
Hangzhou 12
Taizhou 12
Tappahannock 12
Guangzhou 10
Toronto 10
Philadelphia 9
Fremont 8
Los Angeles 8
London 6
Warsaw 6
Changchun 5
Lanzhou 5
Rome 5
Auburn Hills 4
Dallas 4
Dong Ket 4
Edinburgh 4
L'aquila 4
Bovisio-Masciago 3
Fuzhou 3
Hefei 3
Monza 3
Napoli 3
Redwood City 3
Sydney 3
São Paulo 3
Wil 3
Xian 3
Adelaide 2
Bologna 2
Brno 2
Budapest 2
Canberra 2
Florence 2
Frankfurt am Main 2
Genoa 2
Haikou 2
Houston 2
Jakarta 2
Maserada Sul Piave 2
Melbourne 2
Ottawa 2
Riyadh 2
Secaucus 2
Shaoxing 2
Springfield 2
Venezia 2
Zagreb 2
Almaty 1
Amsterdam 1
Athens 1
Baotou 1
Bari 1
Belgrade 1
Berlin 1
Bowie 1
Bremen 1
Brisbane 1
Cairo 1
Calolziocorte 1
Totale 5.969
Nome #
LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study 96
Mediastinoscopia: criterio di operabilità nel carcinoma polmonare. 87
Randomized trial of sequential administration of G-CSF and GM-CSF versus G-CSF alone following peripheral blood progenitor cell autograft in solid tumors. 84
Previsione di exeresi delle masse mediastiniche in base ai reperti della tomografia computerizzata. 84
Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of a phase II study 83
La chemioterapia intraportale nei pazienti con adenocarcinoma del colon retto operati radicalmente 82
Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study. Clinic Ter 150:269, 1999 80
A controlled study of a new mucolitic drug in pulmonary surgery 79
Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer 79
Gli immunocomplessi nel carcinoma polmonare: correlazione con lo studio clinico e l’istotipo. 78
Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX. 78
Low dose interleukin-2 and 13-cis-retinoic acid as maintenance therapy in patients with solid tumors responsive to chemotherapy 77
Interleukin-2 (IL-2) and 13-cis retinoic acid (RA) decrease vascular endothelial growth factor (VEGF) and prolong clinical benefit in patients with advanced solid tumors showing a partial response (PR) or stable disease (SD) to chemotherapy. J Clin Oncol 2005: 2, 27s (supplement). 77
Carboplatin, Ifosfamide and Vinorelbine in the Treatment of Advanced Non Small Cell Lung Cancer. A Phase II Study. Am J Clin Oncol 22:57-61, 1999. 76
Contenuto dei grassi nella dieta e rischio di insorgenza di carcinoma della mammella. 76
Carcinoma bronchiolo-alveolare: un tipo “eccentrico” di carcinoma polmonare 74
Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma 72
Calcitonina plasmatica immunoreattivi nel carcinoma del polmone. 72
Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier 72
Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer 71
Alternating XELFOX and XELFIRI in patients with metastatic colorectal cancer 71
Il timo nel paziente con carcinoma del polmone: possibili correlazioni morfofunzionali. 70
La tomografia computerizzata nella valutazione del coinvolgimento mediastinico da carcinoma polmonare. 70
Timo e neoplasia polmonare. Correlazioni fra morfologia e funzione dei linfociti timici. 69
Significato diagnostico degli immunocomplessi nel carcinoma polmonare. 69
Calcitonina plasmatica immunoreattiva (ir-CT) nel carcinoma del polmone: la nostra esperienza personale. 69
Primitive sarcoma of the breast: New insight on the proper surgical management 69
Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer. A pilot study 68
5-fluorouracil-carboplatin continuous infusion in advanced cancer. 68
Dati preliminari per un monitoraggio immunologico nel carcinoma polmonare. 68
Sequential chemotherapy, beta interferon, retinoids and tamoxifen in the treatment of metastatic breast cancer. A pilot study. 68
Anthracycline‑based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5‑fluorouracil and radiation therapy in surgically resected axillary node‑positive breast cancer 68
A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer 68
A new sphincter-splitting operation for surgical access to lying tumours of the rectum 67
Condrosarcoma della prima costa – Problemi di tecnica chirurgica. 67
Ormoni calciotropi nelle neoplasie polmonari. 67
[Clinical, radiological and manometric study in total esophagoplasties] 67
Traitement des pancreatites aigues necrotiques par laparotomie Traitement des pancreatites aigues necrotiques par laparotomie 67
Immunotherapy in patients with less than complete response to chemotherapy 66
Gemcitabine, ifosfamide, and vinorelbine in advanced non-small cell lung cancer: A phase II study. 66
High-dose carboplatin, cyclophosphamide, etoposide with hematological growth factors, without stem cell support in patients with advanced cancer. 66
Metodi palliativi nel carcinoma dell'esofago 66
Changing treatment paradigm in patients with advanced solid tumors 66
A multicenter¸open label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high risk, early breast cancer (HRBC). A multicenter¸open label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high risk, early breast cancer (HRBC). J Clin Oncol 30: 2012 (ASCO MEETING ABSTRACTS May 30, 2012:e11041 ASCO MEETING ABSTRACTS May 30, 2012:e11041 66
5-fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma: A multicentre randomised controlled trial 66
Maintenance immunotherapy in metastatic breast cancer 66
Phase I-II study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer 65
Gli immunocomplessi circolanti nel carcinoma polmonare: correlazione con i fattori prognostici 65
Adjuvant BCG – therapy in operated patients with stage I and II squamos cell carcinoma of the lung. 65
Primary chemotherapy in stage IV ovarian cancer. A prospective phase II study 65
La terapia adiuvante con BCG non intrapleurico nel carcinoma polmonare resecato. 65
Long-term Follow-up of Pegylated Liposomal Doxorubicin and Oxaliplatin in Recurrent Ovarian Cancer 65
Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer 64
A new sphincter-splitting procedure for low-lying tumours of the rectum 64
Le traitment adjuvant des adenocarcinomes colique operee'. 64
Phase II study of pegylated liposomal doxorubicin (PLD) and oxaliplatin (L-OHP) in recurrent Ovarian Cancer (ROC). Ann Oncol 17;supplement 9,2006,abstract 5380. 64
Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer. 64
HPLC determination of urinary catecholamines as a screening test for pheochromocytoma in a patient with medullary carcinoma of the thyroid. Gi 64
5-fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus - A multicenter randomized trial 63
Maintenance immunotherapy in recurrent ovarian cancer: long term follow-up of a phase II study 63
Ventral incisional hernias: incidence, date of recurrence, localization and risk factors 63
.Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with chemotherapy. Eortc symposium on gastrointestinal, liver and pancreatic cancer. Tumori, 2002, S 84, ABSTRACT # 121. 63
Interleukin-2 (IL-2) with 13-cis retinoic acid (RA) is more effective than IL-2 alone, as maintenance therapy in advanced cancer responsive to chemotherapy. Final result of a phase-II randomized trial. Proc Am Ass Cancer Res 2004: 45;1082. Abstract #4684. 63
Randomized trial of filgrastim versus sequential filgrastim and molgramostim after dose intensified carboplatin, cyclophposphamide and etoposide. A phase I pilot Study. 62
Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma 62
Chemoradioimmunotherapy in Locally Advanced Pancreatic and Biliary Tree Adenocarcinoma: A Multicenter Phase II Study 62
Metastatic breast cancer in the elderly: treatment with beta interferon, retinoids and tamoxifen: a phase II study. 62
Exeresi bifocale nel trattamento del carcinoma polmonare con metastasi cerebrale isolata. 62
Splenic rupture secondary to pancreatic pseudocist. A review of the literature and three additional case reports. 62
Beta interferon, retinoids and tamoxifen in the treatment of metastatic breast cancer. 62
Multicenter Phase II Study of CPT-11 Fractionated over Two Days with Bimonthly Leucovorin and 5-Fluorouracil in Patients with Metastatic Colorectal Cancer. 61
Premenopausal hormone-responsive breast cancer with extensive axillary nodes involvement: total estrogen blockade and chemotherapy 61
The current state of adjuvant treatment in carcinoma of the resected colon ( Review ) [Stato attuale del trattamento adiuvante del carcinoma del colon resecato.] 60
Maintenance Immunotherapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck 60
Wich is the best treatment of the pulmonary microcytoma 60
La nostra esperienza con la suturatrice automatica TA-30 nelle resezioni polmonari 60
Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, -interferon and retinoids. 60
La resezione epatica per tumori metastatici 60
Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy 60
Cyst of Canal of Nuck: Our Experience 60
Fluorouracile, cis-platino e retinolo palmitato nel trattamento delle neoplasie del cavo orale in fase avanzata. Studio di fase II. 59
Beta-interferon, retinoids and tamoxifen combination in advanced breast cancer. 59
Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer, pre-treated with chemotherapy. 59
Multicenter phase II study of sequential chemotherapy, radiotherapy, and immunotherapy in locally advanced pancreatic (Pa) and biliary tree (Bt) adenocarcinoma (ADK). J Clin Oncol 27:15s, 2009 (suppl; abstr 3047. 58
Multicenter phase II study of gemcitabine, vinorelbine and ifosfamide in advanced non-small cell lung cancer. Annals of Oncology 2000: 11,10, supplement 2, A40,abstract. 58
Cisplatin, vindesine, mitomycin-c and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II pilot study. Anticancer Res. 20:1985-90, 2000. 57
Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin‑eluting beads compared with lipiodol 57
Chemo-immunotherapy in advanced head and neck cancer. Anticancer Res 19:773-7, 1999. 57
Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status 57
It May Happen: Endometrioma from Hemorrhagic Corpus Luteum 57
Phase II study of epirubicin, mitomycin-c, and 5-fluorouracil In hormone-refractory prostatic carcinoma. 56
Il trattamento immunoterapico nei carcinomi primitivi della laringe: primi risultati della nostra esperienza. 56
Il monitoraggio immunologico nel carcinoma polmonare: correlazione con lo stadio clinico e l’istotipo. 56
Combined 5-fluorouracil infusion with Fractionated epirubicin and cyclophosphamide in advanced breast Cancer. 56
False Positive also Exists: Keep it in Mind when Dual Test is Performed 56
Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study 55
Phase IB study of subcutaneously administered Interleukin-2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer. 55
Fattori prognostici negli adenocarcinomi mammari non metastatici 55
Esiste un trattamento adiuvante efficace nel carcinoma del colon resecato? 55
High-dose chemotherapy with peripheral progenitor cell support (HDC-PBPCS) and immunotherapy in the treatment of advanced cancer. Long-term results. Annals of Oncology 2001:12,87,supplement 4.I10,abstract. 55
Totale 6.593
Categoria #
all - tutte 34.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020728 0 0 0 12 5 161 208 5 153 29 3 152
2020/20211.214 14 153 0 150 149 45 151 3 168 45 284 52
2021/2022983 46 131 164 44 29 10 8 51 46 33 68 353
2022/20232.706 205 130 94 249 303 297 1 171 1.137 15 70 34
2023/2024491 105 42 23 137 27 99 7 19 1 6 10 15
2024/2025275 13 23 223 16 0 0 0 0 0 0 0 0
Totale 8.817